Ironwood Pharmaceuticals Inc
(NAS:IRWD)
$
4.485
0.295 (7.04%)
Market Cap: 716.43 Mil
Enterprise Value: 1.21 Bil
PE Ratio: 112.13
PB Ratio: 0
GF Score: 51/100 Ironwood Pharmaceuticals Inc at Bank of America Merrill Lynch Health Care Conference Transcript
May 14, 2019 / 03:00PM GMT
Release Date Price:
$9.8
Ying Huang
BofA Merrill Lynch, Research Division - Director in Equity Research
Okay. Good morning. Welcome to the Annual Bank of America Merrill Lynch Global Healthcare Conference in Las Vegas. And my name is Ying Huang. I'm the head of biotech equity research here at BofA Merrill Lynch. Welcome, everyone.
And today is the first day, and we'll kick off with our first presenting company, Ironwood Pharma. I'm pleased to have Mark Mallon, Chief Executive Officer of Ironwood; and also Gina Consylman, the CFO of the company, with us.
So with that, I guess we'll use the fireside format. So welcome and -- Mark.
Mark Mallon
Ironwood Pharmaceuticals, Inc. - CEO & Director
Thank you.
Gina R. Consylman
Ironwood Pharmaceuticals, Inc. - CFO, Senior VP & Treasurer
Thank you.
Questions & Answers
Ying Huang
BofA Merrill Lynch, Research Division - Director in Equity Research
So maybe I'll kick off by asking you about LINZESS, obviously, the most
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot